Biodexa Pharmaceticals (BDRX) — Working Capital to Net Assets Ratio
Biodexa Pharmaceticals (BDRX) has a Working Capital to Net Assets ratio of 55.4% as of December 2025. Working capital of $6.30 Million (current assets of $12.42 Million minus current liabilities of $6.12 Million) is measured against net assets of $11.38 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Biodexa Pharmaceticals (BDRX) balance sheet quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Biodexa Pharmaceticals Working Capital to Net Assets (2012–2025)
This chart shows how Biodexa Pharmaceticals's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the ratio stands at 55.4%, reflecting working capital of $6.30 Million against net assets of $11.38 Million USD. Check BDRX tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Biodexa Pharmaceticals (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Biodexa Pharmaceticals from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Biodexa Pharmaceticals market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 55.4% | $6.30 Million | $11.38 Million | $12.42 Million | $6.12 Million | ▲ +10.0 pp |
| 2024 | 45.4% | $3.78 Million | $8.32 Million | $8.81 Million | $5.03 Million | ▲ +14.1 pp |
| 2023 | 31.2% | $1.46 Million | $4.68 Million | $7.03 Million | $5.57 Million | ▼ -56.9 pp |
| 2022 | 88.2% | $2.79 Million | $3.16 Million | $4.69 Million | $1.90 Million | ▼ -6.7 pp |
| 2021 | 94.9% | $9.92 Million | $10.45 Million | $11.76 Million | $1.84 Million | ▲ +1.3 pp |
| 2020 | 93.6% | $6.29 Million | $6.72 Million | $9.28 Million | $2.99 Million | ▲ +52.3 pp |
| 2019 | 41.3% | $8.07 Million | $19.56 Million | $13.74 Million | $5.67 Million | ▲ +22.7 pp |
| 2018 | 18.6% | $3.15 Million | $16.92 Million | $5.62 Million | $2.47 Million | ▼ -10.9 pp |
| 2017 | 29.5% | $10.22 Million | $34.68 Million | $18.58 Million | $8.36 Million | ▲ +1.1 pp |
| 2016 | 28.3% | $12.96 Million | $45.72 Million | $22.30 Million | $9.35 Million | ▲ +4.4 pp |
| 2015 | 24.0% | $11.23 Million | $46.89 Million | $20.33 Million | $9.10 Million | ▼ -44.6 pp |
| 2014 | 68.6% | $28.80 Million | $41.99 Million | $31.63 Million | $2.83 Million | ▼ -168.3 pp |
| 2013 | 236.8% | $1.80 Million | $760.00K | $4.09 Million | $2.29 Million | ▲ +158.9 pp |
| 2012 | 77.9% | $-6.45 Million | $-8.28 Million | $1.78 Million | $8.23 Million | — |